Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
BIOSYNTH AG currently has 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are being handled by 3 distinct examiners, which indicates that no single official is responsible for more than one case. This arrangement requires the applicant to adapt to the specific preferences and legal interpretations of different individuals. The absence of examiner concentration suggests that the prosecution of these matters will proceed along independent tracks.
The company's active cases are distributed across 3 distinct art units, highlighting the technical variety within their biotechnological filings. This spread means that the applications may be subject to different internal guidelines and examination speeds. RODRIGUEZ, RAYNA B is identified as the busiest examiner for the portfolio, currently managing 1 pending office action. Since this busiest examiner is responsible for a single case, the workload is not concentrated in any one office.
For those managing the portfolio, the use of multiple examiners across various art units necessitates a careful review of all correspondence to ensure technical consistency. The fact that RODRIGUEZ, RAYNA B holds 1 pending action means that the other files are being reviewed by separate officials. This distribution provides a diversified exposure to the patent office's examination corps for the active cases currently in progress.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| §112 only | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RODRIGUEZ, RAYNA B | 1 | 33.6% | +19.2% |
| MCINTOSH III, TRAVISS C | 1 | 73.3% | +14.1% |
| WHITE, ASHLEY TAYLOR | 1 | 23.8% | +36.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18041682 | POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE | RODRIGUEZ, RAYNA B | 5d overdue |
| 17908886 | LUCIFERASE-BASED METHODS FOR DETECTING BACTERIAL AND FUNGAL CELLS AND ASSESSING SUSCEPTIBILITY OF BACTERIAL CELLS TO ANTIBIOTICS | WHITE, ASHLEY TAYLOR | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18041682 | POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE | RODRIGUEZ, RAYNA B | 5d overdue |
| 18271401 | METHOD OF MAKING NICOTINAMIDE RIBOFURANOSIDE SALTS BY SALT METATHESIS, THE CRYSTALLINE FORM OF ITS TOSYLATE SALT AND THE CO-CRYSTALLIZED FORM OF ITS CHLORIDE:IODIDE SALT | MCINTOSH III, TRAVISS C | — |
| 17908886 | LUCIFERASE-BASED METHODS FOR DETECTING BACTERIAL AND FUNGAL CELLS AND ASSESSING SUSCEPTIBILITY OF BACTERIAL CELLS TO ANTIBIOTICS | WHITE, ASHLEY TAYLOR | — |
| Art Unit | Apps |
|---|---|
| 1628 | 1 |
| 1693 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18041682 | POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE | RODRIGUEZ, RAYNA B | 1628 | §102§103§112 | Non-Final OA | 5d overdue | Pending | Oct 27, 2023 |
| 18271401 | METHOD OF MAKING NICOTINAMIDE RIBOFURANOSIDE SALTS BY SALT METATHESIS, THE CRYSTALLINE FORM OF ITS TOSYLATE SALT AND THE CO-CRYSTALLIZED FORM OF ITS CHLORIDE:IODIDE SALT | MCINTOSH III, TRAVISS C | 1693 | §112 | Non-Final OA | — | Pending | Jul 07, 2023 |
| 17908886 | LUCIFERASE-BASED METHODS FOR DETECTING BACTERIAL AND FUNGAL CELLS AND ASSESSING SUSCEPTIBILITY OF BACTERIAL CELLS TO ANTIBIOTICS | WHITE, ASHLEY TAYLOR | 1653 | §103 | Non-Final OA | — | Pending | Sep 01, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBIOSYNTH AG has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Rayna B Rodriguez has the most, with 1 of BIOSYNTH AG's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
